QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
NASDAQ:LBPS

4D pharma News Headlines

$6.75
-0.37 (-5.20 %)
(As of 09/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.75
$7.10
50-Day Range
$6.75
$10.10
52-Week Range
$6.75
$15.50
Volume116,815 shs
Average Volume22,837 shs
Market Capitalization$110.92 million
P/E RatioN/A
Dividend YieldN/A
Beta0.04

Media Mentions By Week

4D pharma Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LBPS
News Sentiment

0.00

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LBPS Articles
This Week

0

0

LBPS Articles
Average Week

Get 4D pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPS and its competitors with MarketBeat's FREE daily newsletter.

4D pharma (NASDAQ LBPS) News Headlines Today

SourceHeadline
MarketBeat logo4D pharma plc (NASDAQ:LBPS) Short Interest Update
americanbankingnews.com - September 14 at 1:06 PM
barrons.com logo4D pharma PLC ADR
barrons.com - August 13 at 11:24 PM
nasdaq.com logo4d Pharma Plc - ADR Shares Approach 52-Week Low - Market Mover
nasdaq.com - August 12 at 3:54 PM
finance.yahoo.com logo4D pharma Announces Two Presentations at European Society for Medical Oncology (ESMO) Congress 2021
finance.yahoo.com - August 2 at 7:36 AM
fool.co.uk logoThis penny stock could double in just 2 years
fool.co.uk - July 27 at 1:39 PM
proactiveinvestors.com logo4D pharma says pre-clinical research points to the potential of its discovery to enhance cancer CAR-T therapies
proactiveinvestors.com - July 6 at 7:56 AM
finance.yahoo.com logo4D pharma Announces Publication of Preclinical Research Showing Single Strain Megasphaera massiliensis improves activity of CAR-T
finance.yahoo.com - July 6 at 7:56 AM
finance.yahoo.com logo4D pharma to Participate in Ladenburg Thalmann Healthcare Conference
finance.yahoo.com - June 29 at 8:17 AM
feeds.benzinga.com logo4D pharma To Stop Testing Asthma Med in COVID-19 Patients
feeds.benzinga.com - June 4 at 10:32 AM
lse.co.uk logo4D Pharma halts enrolment for Covid treatment trial, focuses on asthma
lse.co.uk - June 4 at 6:37 AM
finance.yahoo.com logo4D pharma to Present Additional Data from Phase II Study of Blautix for the Treatment of Irritable Bowel Syndrome at Digestive Disease Week (DDW) 2021
finance.yahoo.com - May 17 at 8:05 AM
reuters.com logoLBPS.OQ - 4d Pharma PLC Profile | Reuters
reuters.com - April 30 at 8:20 PM
Get 4D pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPS and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.